药品评价
藥品評價
약품평개
Drug Evaluation
2015年
14期
44-46
,共3页
卵巢神经内分泌小细胞癌%手术%化疗%治疗效果
卵巢神經內分泌小細胞癌%手術%化療%治療效果
란소신경내분비소세포암%수술%화료%치료효과
ovarian neuroendocrine small cell carcinoma%surgery%chemotherapy%treatment effect
卵巢神经内分泌小细胞癌是一种罕见的卵巢癌类型,但其病死率非常高,对妇女生命造成了严重的威胁.该疾病在治疗上尚无有效完善的治疗方案,目前手术治疗仍是主要的治疗手段,多主张以铂类为基础的联合化疗,更倾向于多药物联合化疗.由于卵巢神经内分泌小细胞癌的病例数较少,治疗方法尚未统一,因此仍需不断从临床总结经验完善的治疗方案,以提高患者的生活质量,延长其生存期.
卵巢神經內分泌小細胞癌是一種罕見的卵巢癌類型,但其病死率非常高,對婦女生命造成瞭嚴重的威脅.該疾病在治療上尚無有效完善的治療方案,目前手術治療仍是主要的治療手段,多主張以鉑類為基礎的聯閤化療,更傾嚮于多藥物聯閤化療.由于卵巢神經內分泌小細胞癌的病例數較少,治療方法尚未統一,因此仍需不斷從臨床總結經驗完善的治療方案,以提高患者的生活質量,延長其生存期.
란소신경내분비소세포암시일충한견적란소암류형,단기병사솔비상고,대부녀생명조성료엄중적위협.해질병재치료상상무유효완선적치료방안,목전수술치료잉시주요적치료수단,다주장이박류위기출적연합화료,경경향우다약물연합화료.유우란소신경내분비소세포암적병례수교소,치료방법상미통일,인차잉수불단종림상총결경험완선적치료방안,이제고환자적생활질량,연장기생존기.
Ovarian neuroendocrine small cell carcinoma is a rare type of ovarian cancer, but its mortality is very high, causing a serious threat to women's lives. The disease is not effective in the treatment of treatment, the current operation is still the main treatment means, more than the proposition of platinum based chemotherapy, more prone to multi drug combination chemotherapy. Because of the small number of small cell carcinoma of the ovary, the treatment has not been unified. Therefore, it is necessary to improve the quality of life and prolong its life.